学术探索
学术期刊
新闻热点
数据分析
智能评审

普拉克索在帕金森病中的应用

被引：30
作者：
余丹丽
张雄
机构：
[1] 温州医学院附属第二医院神经内科
来源：
实用医学杂志 | 2009年 / 25卷 / 01期
关键词：
普拉克索; 左旋多巴; 患者; 帕金森病; 麦角类多巴胺受体激动剂;
D O I：
暂无
中图分类号：
R742.5 [震颤麻痹综合征];
学科分类号：
摘要：
<正>帕金森病(Parkinson′s disease)是一种常见的发生于中老年人的缓慢进展的神经系统变性性疾病,临床以静止性震颤、肌强直和运动障碍为主要特征。随着人口老年化的进程,其患病率逐年增高,已成为仅次于脑血管病的神经系统常见病。长期以来,以左旋多巴为主的药物替代治疗是帕金
引用
收藏
页码：20 / 21
页数：2
相关论文
共 8 条
  • [1] Blood–brain barrier transport of pramipexole, a dopamine D 2 agonist[J] . Takashi Okura,Rie Ito,Naoki Ishiguro,Ikumi Tamai,Yoshiharu Deguchi.Life Sciences . 2007 (17)
  • [2] Pramipexole prevents neurotoxicity induced by oligomers of beta-amyloid
    Uberti, Daniela
    Bianchi, Irene
    Olivari, Luca
    Ferrari-Toninelli, Giulia
    PierLuigi, Canonico
    Memo, Maurizio
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 569 (03) : 194 - 196
  • [3] Pramipexole versus Levodopa in Patients with Early Parkinson’s Disease: Effect on Generic and Disease-Specific Quality of Life[J] . Katia Noyes,Andrew W. Dick,Robert G. Holloway.Value in Health . 2006 (1)
  • [4] Conversion from dopamine agonists to pramipexole[J] . G. Linazasoro.Journal of Neurology . 2004 (3)
  • [5] The effect of repeated treatment with pramipexole on the central dopamine D3 system
    Maj, J
    Rogóz, Z
    Margas, W
    Kata, M
    Dziedzicka-Wasylewska, M
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (12) : 1369 - 1379
  • [6] The dopamine agonist pramipexole scavenges hydroxyl free radicals induced by striatal application of 6-hydroxydopamine in rats: an in vivo microdialysis study[J] . Boris Ferger,Peter Teismann,Joachim Mierau.Brain Research . 2000 (2)
  • [7] Novel neuroprotective mechanisms of pramipexole, an anti-Parkinson drug, against endogenous dopamine-mediated excitotoxicity. Izumi,Y,Sawada,H,Yamamoto,N. European Journal of Pharmacology . 2007
  • [8] Pramipexole vs.levodopa as initialtreatment for Parkinsons’disease. The Parkinson Study Group. The Journal of The American Medical Association . 2000
1